Centiva Capital, LP Bristol Myers Squibb CO Call Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $594,952 - $674,560	12,400 Added 122.77%	22,500 $1.22 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $363,600 - $433,875	-7,500 Reduced 42.61%	10,100 $518,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $277,872 - $310,704	4,800 Added 37.5%	17,600 $1.02 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $2.73 Million - $3.03 Million	-42,900 Reduced 77.02%	12,800 $818,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $1.44 Million - $1.63 Million	-21,900 Reduced 28.22%	55,700 $3.86 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $5.82 Million - $6.89 Million	-85,000 Reduced 52.28%	77,600 $5.58 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $9,165 - $5.42 Million	70,500 Added 76.55%	162,600 $11.6 Million
Q2 2022 Aug 17, 2022	BUY	$72.62 - $79.98 $4 Million - $4.41 Million	55,100 Added 148.92%	92,100 $7.09 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $1.46 Million - $1.75 Million	23,800 Added 180.3%	37,000 $2.7 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $637,124 - $742,737	11,880 Added 900.0%	13,200 $823,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $1.89 Million - $2.21 Million	-31,880 Reduced 96.02%	1,320 $78,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $43,337 - $47,194	700 Added 2.15%	33,200 $2.22 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $1.09 Million - $1.43 Million	-22,200 Reduced 40.59%	32,500 $2.08 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $1.93 Million - $2.5 Million	39,600 Added 262.25%	54,700 $2.84 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $833,369 - $939,975	15,100 New	15,100 $937,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.32 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.46 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.58 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.58 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account